作者: evince 時間: 2025-3-21 22:08 作者: 結(jié)束 時間: 2025-3-22 04:25
https://doi.org/10.1007/978-3-662-02617-5e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot作者: mastoid-bone 時間: 2025-3-22 08:04
Book 2021 difficile. helps the reader gain a better understanding of C. difficile, the challenges that may arise and the available treatment options. Given its broad coverage and features, it will appeal to a wide readership, from gastroenterologists through general physicians, nurses, and other healthcare p作者: entice 時間: 2025-3-22 09:05
Epidemiology,on which inactivated a negative regulator of the toxin production (tcdC) in the pathogenicity locus. Over the last years a large number of different ribotypes of . have been identified by international surveillance programs. Recurrence of CDI is occurring in 10–25% of patients after a primary infect作者: construct 時間: 2025-3-22 14:51
Treatment of CDI,a has been claimed to provide the best protection against CDI, resulting in the suggestion to support the gut microbiota with products containing probiotic bacteria (probiotics or synbiotics). Despite positive reports, clinical evidence is still slim to support a recommendation of these products for作者: construct 時間: 2025-3-22 17:24
Summary and Discussion,e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot作者: 大都市 時間: 2025-3-22 23:48 作者: Mindfulness 時間: 2025-3-23 01:54
Diagnosis of CDI,on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.作者: Accolade 時間: 2025-3-23 05:59
https://doi.org/10.1007/978-3-642-88138-1on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.作者: Meditative 時間: 2025-3-23 12:59 作者: BARB 時間: 2025-3-23 15:51 作者: 某人 時間: 2025-3-23 20:49 作者: 禁止 時間: 2025-3-23 23:27
Helmut Remschmidt,Frank M. Theisenxygen in its environment, . forms metabolically inactive spores, which allow the bacterium to survive for a long time. Spore formation (sporulation) is a complex process resulting in the encapsulation of the bacterium, which protects vital components (DNA and proteins) against destruction by hazardo作者: Maximizer 時間: 2025-3-24 02:23 作者: Engaged 時間: 2025-3-24 07:03 作者: lambaste 時間: 2025-3-24 14:27
A. Schaub,P. Kümmler,L. Gauck,S. Amannon and increased length of staying in a hospital are associated with an increased risk for CDI. Exposure to antibiotics is a dominant risk for the development of CDI. Therapies with certain antibiotics (e.g., clindamycin and fluoroquinolones) have been identified as carrying particular high CDI risk作者: Neuropeptides 時間: 2025-3-24 16:10 作者: 動物 時間: 2025-3-24 21:04 作者: 蛛絲 時間: 2025-3-24 23:38
https://doi.org/10.1007/978-3-642-79738-5ncomycin remain the cornerstones of CDI treatment. However, the first . strains have emerged which exhibit a reduced susceptibility against these two antibiotics. Fidaxomicin, a recently approved narrow-spectrum macrocyclic antibiotic, is hardly absorbed from the intestine when given orally. Fidaxom作者: MELD 時間: 2025-3-25 04:38
https://doi.org/10.1007/978-3-642-79738-5. Based on currently available data and their excellent safety profile, probiotics and synbiotics are recommended for CDI prophylaxis. Evidence-based data supporting the usage of probiotics and synbiotics for prophylaxis of CDI is emerging but is still too limited to justify listing in medical guide作者: Mirage 時間: 2025-3-25 08:32 作者: Habituate 時間: 2025-3-25 12:20
Henning Sommermeyer,Jacek Pi?tekOffers a comprehensive and up to date overview on Clostridioides difficile and C. difficile infections.Covers all relevant scientific aspects, from microbiology, and pathophysiology, to risk factors, 作者: Madrigal 時間: 2025-3-25 19:13 作者: Basilar-Artery 時間: 2025-3-25 23:22
s, from microbiology, and pathophysiology, to risk factors, .The book provides a comprehensive overview of the current knowledge about Clostridioides (C.) difficile (formerly known as Clostridium difficile) and Clostridioides difficile infections (CDI)...The diseases caused by C. difficile range fro作者: nettle 時間: 2025-3-26 01:21
Helmut Remschmidt,Frank M. Theisenent pathways, triggered by specific factors (glycine, taurocholate, Ca.) being present in the gut of the host. Vegetative cells will proliferate as long as environmental conditions allow, or enter into sporulation in case of being exposed to oxygen or encountering a lack of nutrients.作者: Arteriography 時間: 2025-3-26 05:25 作者: CONE 時間: 2025-3-26 09:10
A. Schaub,P. Kümmler,L. Gauck,S. Amannevious CDI. A common denominator of risk factors for CDI is the association of the risk factor with a disturbed balance of the gut microbiota which is believed to result in the loss of colonization resistance which is normally keeping the uncontrolled proliferation of . in the gut at bay.作者: phytochemicals 時間: 2025-3-26 16:04 作者: 滲透 時間: 2025-3-26 17:55 作者: miracle 時間: 2025-3-26 21:16
Risk Factors for CDI,evious CDI. A common denominator of risk factors for CDI is the association of the risk factor with a disturbed balance of the gut microbiota which is believed to result in the loss of colonization resistance which is normally keeping the uncontrolled proliferation of . in the gut at bay.作者: Atmosphere 時間: 2025-3-27 03:08 作者: chapel 時間: 2025-3-27 09:06
Gerd Huber,Gisela Gross,Reinhold Schüttlern of CDI is pseudomembranous colitis (PCM) with toxic megacolon, colon perforation, intestinal paralysis, kidney failure, systemic inflammatory response syndrome, septicemia, and death. Mortality rate directly related to CDI is about 5%, while mortality associated with CDI complications is between 15–25% and up to 34% in intensive care units.作者: Nonconformist 時間: 2025-3-27 09:32 作者: Muscularis 時間: 2025-3-27 14:47 作者: Derogate 時間: 2025-3-27 18:35 作者: 和諧 時間: 2025-3-28 01:01 作者: Paleontology 時間: 2025-3-28 02:44 作者: Relinquish 時間: 2025-3-28 06:24 作者: addict 時間: 2025-3-28 11:18
Microbiology,xygen in its environment, . forms metabolically inactive spores, which allow the bacterium to survive for a long time. Spore formation (sporulation) is a complex process resulting in the encapsulation of the bacterium, which protects vital components (DNA and proteins) against destruction by hazardo作者: 法官 時間: 2025-3-28 14:42
Pathophysiology of ,and TcdB. Both toxins are glycosyltransferases, which deactivate certain GTP-binding proteins (Rho, Rac, and Cdc-42) within gut epithelial cells, resulting in the modulation of numerous physiological events in the cells and contributing directly to disease manifestation. Both toxins are capable of m作者: amorphous 時間: 2025-3-28 21:50
Epidemiology, ecology of infants. With the widespread use of antibiotics in the late 1940s and early 1950s, antibiotic-associated diarrhea and pseudomembranous colitis (PMC) became more frequent. It took until the 1970s that . was identified as a frequent cause for antibiotic-associated diarrhea and the major ca作者: tinnitus 時間: 2025-3-29 00:05
Risk Factors for CDI,on and increased length of staying in a hospital are associated with an increased risk for CDI. Exposure to antibiotics is a dominant risk for the development of CDI. Therapies with certain antibiotics (e.g., clindamycin and fluoroquinolones) have been identified as carrying particular high CDI risk作者: 松緊帶 時間: 2025-3-29 05:58
Diagnosis of CDI,on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step作者: 詢問 時間: 2025-3-29 08:19
Clinical Picture of CDI, commonly affecting the distal part of the colon. Most patients suffer from mild diarrhea and recover spontaneously after 5–10?days of antibiotic withdrawal. In addition to diarrhea, patients experience abdominal pain, fever, nausea and vomiting, weakness, and loss of appetite. Severe CDI is charact作者: 現(xiàn)代 時間: 2025-3-29 14:11
Treatment of CDI,ncomycin remain the cornerstones of CDI treatment. However, the first . strains have emerged which exhibit a reduced susceptibility against these two antibiotics. Fidaxomicin, a recently approved narrow-spectrum macrocyclic antibiotic, is hardly absorbed from the intestine when given orally. Fidaxom作者: MILK 時間: 2025-3-29 17:54
